

Cover Story
Faculty members at MD Anderson Cancer Center are arguably the most intensely watched cohort in academic medicine. Their angst has been measured four times by three administrative entities over two years.
In Brief


Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
- The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.” - HHS (again) postpones USPSTF meeting










